However, considering that GlaxoSmithKline holds an 8% stake in Curevac and has also entered into other partnerships with Sanofi to develop special RNA specifications for Corona, all of which have failed, I wonder who is the real player in this game.
•
33
•
@Qheherain Yes, that could be another impetus for the lawsuit. But I was more interested in the financial outlook, because I've been looking at developments here for some time now, and I've been counting on the assumption that the state will step in.
••